Your browser doesn't support javascript.
loading
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study.
Uldrick, Thomas S; Gonçalves, Priscila H; Abdul-Hay, Maher; Claeys, Alisa J; Emu, Brinda; Ernstoff, Marc S; Fling, Steven P; Fong, Lawrence; Kaiser, Judith C; Lacroix, Andreanne M; Lee, Steve Y; Lundgren, Lisa M; Lurain, Kathryn; Parsons, Christopher H; Peeramsetti, Sharavi; Ramaswami, Ramya; Sharon, Elad; Sznol, Mario; Wang, Chia-Ching Jackie; Yarchoan, Robert; Cheever, Martin A.
Afiliação
  • Uldrick TS; Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington.
  • Gonçalves PH; HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Abdul-Hay M; HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Claeys AJ; Northwell Health Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lake Success, New York.
  • Emu B; Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York.
  • Ernstoff MS; Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington.
  • Fling SP; Yale University, New Haven, Connecticut.
  • Fong L; Roswell Park Cancer Institute, Buffalo, New York.
  • Kaiser JC; Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington.
  • Lacroix AM; University of California San Francisco, San Francisco.
  • Lee SY; Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington.
  • Lundgren LM; Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington.
  • Lurain K; Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York.
  • Parsons CH; Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington.
  • Peeramsetti S; HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Ramaswami R; Louisiana State University Health Science Center, New Orleans.
  • Sharon E; Pardee Center for Infectious Diseases, University of North Carolina Health Care, Hendersonville.
  • Sznol M; Axio Research, Seattle, Washington.
  • Wang CJ; HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Yarchoan R; HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Cheever MA; Yale University, New Haven, Connecticut.
JAMA Oncol ; 5(9): 1332-1339, 2019 Sep 01.
Article em En | MEDLINE | ID: mdl-31154457

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: JAMA Oncol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: JAMA Oncol Ano de publicação: 2019 Tipo de documento: Article